|1.||Soini, Ylermi: 12 articles (12/2015 - 08/2003)|
|2.||Kinnula, Vuokko L: 9 articles (01/2013 - 03/2002)|
|3.||Yu, Dae-Yeul: 8 articles (01/2015 - 03/2007)|
|4.||Kang, Sang Won: 8 articles (10/2013 - 08/2003)|
|5.||Ishii, Tetsuro: 6 articles (11/2015 - 10/2009)|
|6.||Karihtala, Peeter: 6 articles (09/2015 - 08/2003)|
|7.||Lee, Dong-Seok: 6 articles (03/2015 - 03/2007)|
|8.||Hampton, Mark B: 6 articles (08/2013 - 03/2007)|
|9.||Rhee, Sue Goo: 6 articles (09/2012 - 12/2005)|
|10.||Yang, Hee-Young: 5 articles (01/2015 - 03/2007)|
02/01/2005 - "Studies of c-Abl(-/-) osteoblasts revealed that c-Abl played a negative role in the induction of peroxiredoxin I (Prx I, Prdx I), an anti-oxidant protein with tumor suppression activity. "
01/01/2016 - "Re: Peroxiredoxin 4: A Novel Secreted Mediator of Cancer Induced Osteoclastogenesis."
10/01/2015 - "We used immunohistochemistry and quantitative polymerase chain reaction to compare expression of mitochondrial peroxiredoxin 3 (PRX3) in CD133(+)CD44(+) Lgr5(+)cells (CSCs) vs CD133(-)CD44(-)Lgr5(-) colon tumor cells (non-CSCs). "
10/01/2015 - "The sulfiredoxin-peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development."
06/01/2015 - "Using mass spectrometry, we identified peroxiredoxin (PRDX) as a secreted mediator of cancer-induced osteoclastogenesis. "
03/19/2007 - "Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin-induced lethal shock."
07/01/2013 - "annexin 11, peroxiredoxin 1, TrpRS), heat-shock/chaperone proteins (e.g. "
05/01/2008 - "Heat-shock protein-27, -70 and peroxiredoxin-II show molecular chaperone function in sickle red cells: Evidence from transgenic sickle cell mouse model."
10/15/2006 - "After hydrogen peroxide treatment or heat shock, peroxiredoxin was detected preferentially as dimers in metastatic L. "
10/01/2005 - "Western blot revealed that heat shock 60 kDa protein, catalase and peroxiredoxin 2 were also up-regulated. "
|3.||Filarial Elephantiasis (Lymphatic Filariasis)
07/01/2012 - "Brugia malayi thioredoxin peroxidase as a potential vaccine candidate antigen for lymphatic filariasis."
02/01/2009 - "An attempt was made to study the immunoprophylactic efficacy of recombinant Brugia malayi transglutaminase (BmTGA) as protein vaccine along with two other recombinant proteins, Brugia malayi abundant larval transcript-2 (BmALT-2) and Brugia malayi thioredoxin peroxidase (BmTPX), in single and multiple antigen form for human lymphatic filariasis. "
06/01/2011 - "Although the antioxidant thioredoxin peroxidase (TPX) is a putative target exploited in vaccine studies of lymphatic filariasis, the high sequence homology with host peroxiredoxins remains a great concern. "
08/01/2013 - "Neutrophil-mediated oxidation of erythrocyte peroxiredoxin 2 as a potential marker of oxidative stress in inflammation."
03/01/2013 - "[Peroxiredoxin triggers post-ischemic inflammation]."
01/01/2012 - "Peroxiredoxin 1 (Prx1) was recently identified as an endogenous ligand for TLR4 that is secreted from CaP cells and promotes inflammation. "
10/01/2009 - "Peroxiredoxin (Prx) I, a ubiquitous antioxidant enzyme, is known to protect against inflammation; however, its role in the allergic inflammation remains unidentified. "
01/01/2006 - "We characterized changes in expression of the antioxidant protein Peroxiredoxin V (PRXV) during airway inflammation. "
09/10/2006 - "Peroxiredoxin V is essential for protection against apoptosis in human lung carcinoma cells."
09/10/2006 - "The goal of our study was to determine the functional role of the novel antioxidant protein Peroxiredoxin V (PrxV), in protection of human lung carcinoma cell lines against apoptosis. "
06/01/2012 - "Downregulation of peroxiredoxin I by a novel fully human phage display recombinant antibody induces apoptosis and enhances radiation sensitization in A549 lung carcinoma cells."
01/01/2009 - "Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma."
05/01/2006 - "Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma."
|1.||Reactive Oxygen Species (Oxygen Radicals)
|7.||Nitric Oxide Synthase (NO Synthase)
|8.||Interleukin-8 (Interleukin 8)
|9.||Pulmonary Surfactants (Pulmonary Surfactant)
|1.||Homologous Transplantation (Allograft)
|3.||Drug Therapy (Chemotherapy)
|4.||Heterologous Transplantation (Xenotransplantation)